N Bijker

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. pmc Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS
    N Bijker
    Department of Radiation Oncology, The Netherlands Cancer Institute Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 87:615-20. 2002
  2. ncbi request reprint Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and
    Nina Bijker
    Department of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:3381-7. 2006
  3. pmc Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
    N Bijker
    Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, CX, 1066, The Netherlands
    Br J Cancer 84:539-44. 2001
  4. ncbi request reprint Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853
    N Bijker
    Departments of Radiation Oncology and Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 19:2263-71. 2001
  5. ncbi request reprint Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
    N Bijker
    Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands
    Eur J Surg Oncol 27:135-40. 2001
  6. ncbi request reprint Ductal carcinoma in situ of the breast; diagnostic assessment and treatment
    E J Th Rutgers
    Department of Surgery, Pathology, and Radiation Oncology, Netherlands Cancer Institute, Amsterdam
    Scand J Surg 91:268-72. 2002
  7. doi request reprint Is DCIS breast cancer, and how do I treat it?
    N Bijker
    Department of Radiation Oncology, Academic Medical Center, P O Box 22700, 1100DE, Amsterdam, The Netherlands
    Curr Treat Options Oncol 14:75-87. 2013
  8. ncbi request reprint Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer 103:1137-46. 2005
  9. ncbi request reprint Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Eur J Cancer 41:1715-23. 2005

Detail Information

Publications9

  1. pmc Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS
    N Bijker
    Department of Radiation Oncology, The Netherlands Cancer Institute Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 87:615-20. 2002
    ..Selection of patients may explain the differences in outcome of the randomised patients, and those not-entered. Thus, the results of this trial may not be applicable to all patients with ductal carcinoma in situ...
  2. ncbi request reprint Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and
    Nina Bijker
    Department of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 24:3381-7. 2006
    ..We analyzed the efficacy of RT with 10 years follow-up on both the overall risk of local recurrence (LR) and related to clinical, histologic, and treatment factors...
  3. pmc Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
    N Bijker
    Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, CX, 1066, The Netherlands
    Br J Cancer 84:539-44. 2001
    ....
  4. ncbi request reprint Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853
    N Bijker
    Departments of Radiation Oncology and Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Clin Oncol 19:2263-71. 2001
    ..Margin status is the most important factor in the success of BCT for DCIS; additionally, young age and symptomatic detection of DCIS have negative prognostic value...
  5. ncbi request reprint Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
    N Bijker
    Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands
    Eur J Surg Oncol 27:135-40. 2001
    ..The risk of local recurrence in itself, and hence the success of BCT for DCIS, may however be influenced by the quality of the initial procedures that were conducted...
  6. ncbi request reprint Ductal carcinoma in situ of the breast; diagnostic assessment and treatment
    E J Th Rutgers
    Department of Surgery, Pathology, and Radiation Oncology, Netherlands Cancer Institute, Amsterdam
    Scand J Surg 91:268-72. 2002
  7. doi request reprint Is DCIS breast cancer, and how do I treat it?
    N Bijker
    Department of Radiation Oncology, Academic Medical Center, P O Box 22700, 1100DE, Amsterdam, The Netherlands
    Curr Treat Options Oncol 14:75-87. 2013
    ....
  8. ncbi request reprint Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer 103:1137-46. 2005
    ..The objective of the current study was to determine the long-term outcome after breast-conservation surgery followed by definitive breast irradiation for women with mammographically detected DCIS of the breast...
  9. ncbi request reprint Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Eur J Cancer 41:1715-23. 2005
    ..Close follow-up after initial breast conservation treatment with radiation is warranted for the early detection of potentially salvageable local and local-regional recurrences...